INSTANLIN
Live / Registered — Registered (as of 31 Jan 2023)
What this means for you
Registered since 31 Jan 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 31 Jan 2029: the §8 declaration of use).
Record
- Serial number
- 97201712
- Registration number
- 6968299
- Mark type
- Word mark
- Filed
- 04 Jan 2022
- Published for opposition
- 15 Nov 2022
- Registered
- 31 Jan 2023
- Next maintenance filing
- §8 declaration of use, due by 31 Jan 2029 (grace period to 31 Jul 2029)
- Attorney of record
- Nazly Aileen Bayramoglu
Goods and services
- Class 005 — Pharmaceuticals: Anti-diabetic pharmaceuticals; Biological preparations for the treatment of endocrine related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for endocrine related diseases and disorders; Insulin; Medicinal herbal preparations; Medicinal preparations for metabolic system related diseases and disorders; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for the treatment of Diabetes; Syringes sold filled with insulin; Syringes sold filled with anti-diabetic pharmaceuticals
Owner
- GAN & LEE PHARMACEUTICALS., BEIJING, CN
- GAN & LEE PHARMACEUTICALS., BEIJING, CN
- GAN & LEE PHARMACEUTICALS., BEIJING, CN
Prior registrations
Prosecution history
- 31 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 15 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Nov 2022 — PUBLISHED FOR OPPOSITION
- 26 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Oct 2022 — ASSIGNED TO EXAMINER
- 07 Jan 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Jan 2022 — NEW APPLICATION ENTERED